Overview
DIA is pleased to present a four-part course in which you will learn about FDA regulations and expectations for the content, submission, and review of Investigational New Drug (IND) Products and the importance of regulatory strategy. This online course focuses on drug and well characterized biological products and not the regulatory process for devices, generic products, OTC products, or traditional biologics.
Have an account?